Cargando…
Second-line treatment for primary central nervous system lymphoma
Failure after first-line treatment was reported in 35–60% of immunocompetent patients with primary central nervous system lymphoma (PCNSL). There are currently no reports focusing on salvage therapy. This review analyses prognostic factors and the efficacy of salvage therapy by focusing on data from...
Autores principales: | Reni, M, Ferreri, A J M, Villa, E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362452/ https://www.ncbi.nlm.nih.gov/pubmed/10027325 http://dx.doi.org/10.1038/sj.bjc.6690083 |
Ejemplares similares
-
How we treat primary central nervous system lymphoma
por: Calimeri, T., et al.
Publicado: (2021) -
Prevention and management of secondary central nervous system lymphoma
por: Bobillo, Sabela, et al.
Publicado: (2022) -
Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review
por: Steffanoni, Sara, et al.
Publicado: (2023) -
Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016) -
Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)